# H&T Presspart acquires global rights to Hovione's dry powder inhaler

H&T Presspart announced the acquisition of global rights to a capsule-based dry powder inhaler developed by Hovione, which will be manufactured and commercialized as PowdAir Plus. The companies will continue to collaborate.

- Type: Acquisition
- Announced: 2017-04-01
- Status: announced
- Products: PowdAir Plus dry powder inhaler
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [H&T Presspart](https://endata.com/companies/5583.md) (acquirer)
- [Hovione](https://endata.com/companies/23243.md) (target)

## Sources

- [oindpnews.com](https://www.oindpnews.com/2017/04/ht-presspart-announces-partnership-with-hovione-and-launches-the-powdair-plus-dpi/), 2017-04-01: "This is a strategically significant partnership for H&T Presspart and underlines our commitment to forging alliances that accelerate the development, global scale-up and commercialization of novel drug delivery solutions for respiratory patients."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.